A look at current literature and work by a statewide initiative can motivate development of policies that help respond to unrepresented patients’ needs.
AMA J Ethics. 2019;21(7):E611-616. doi:
10.1001/amajethics.2019.611.
When patients are unable to express their wishes and do not have surrogates or advance directives, which and whose values should inform decision making for them? We discuss ethical complexities of caring for unrepresented patients.
Samuel G. Ruchman, Prabhjot Singh, MD, PhD, and Anna Stapleton
What can American health systems developers learn from abroad? Leading programs draw on global lessons to build sustainable and effective care in the US.
AMA J Ethics. 2016;18(7):736-742. doi:
10.1001/journalofethics.2016.18.7.msoc1-1607.
Changes made in 2017 to the World Medical Association Physician’s Pledge strive to keep in step with geopolitical trends by addressing patient autonomy and collegiality.
AMA J Ethics. 2019;21(9):E796-800. doi:
10.1001/amajethics.2019.796.